Acute lymphocytic leukaemia
RecruitingTesting inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia
Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia
- Disease:Acute lymphocytic leukaemia
- Substances:BlinatumomabCyclophosphamide+15
Réunion- Participants:0–17 years · 18–64 years
- Substances:Blinatumomab
- Sponsor:Charite Universitaetsmedizin Berlin KöR










